"Glutamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells.
Descriptor ID |
D005973
|
MeSH Number(s) |
D12.125.068.330 D12.125.095.461 D12.125.154.424
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Glutamine".
Below are MeSH descriptors whose meaning is more specific than "Glutamine".
This graph shows the total number of publications written about "Glutamine" by people in this website by year, and whether "Glutamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 1 | 2 |
1997 | 1 | 0 | 1 |
1998 | 1 | 1 | 2 |
1999 | 1 | 0 | 1 |
2001 | 3 | 0 | 3 |
2002 | 0 | 1 | 1 |
2003 | 3 | 1 | 4 |
2005 | 2 | 1 | 3 |
2006 | 1 | 0 | 1 |
2007 | 2 | 0 | 2 |
2008 | 1 | 1 | 2 |
2009 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2011 | 1 | 1 | 2 |
2012 | 0 | 1 | 1 |
2013 | 3 | 0 | 3 |
2014 | 0 | 3 | 3 |
2015 | 1 | 3 | 4 |
2016 | 0 | 5 | 5 |
2017 | 1 | 2 | 3 |
2018 | 2 | 2 | 4 |
2019 | 1 | 5 | 6 |
2020 | 1 | 1 | 2 |
2021 | 1 | 5 | 6 |
2022 | 1 | 3 | 4 |
2023 | 0 | 1 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glutamine" by people in Profiles.
-
Androgen signaling restricts glutaminolysis to drive sex-specific Th17 metabolism in allergic airway inflammation. J Clin Invest. 2024 Oct 15; 134(23).
-
Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8 T Cells. J Immunol. 2023 08 15; 211(4):563-575.
-
In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma. Sci Adv. 2022 12 16; 8(50):eabp8293.
-
Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial. JAMA Oncol. 2022 10 01; 8(10):1411-1418.
-
In vivo isotope tracing reveals a requirement for the electron transport chain in glucose and glutamine metabolism by tumors. Sci Adv. 2022 09 02; 8(35):eabn9550.
-
Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment. Blood. 2022 08 11; 140(6):630-643.
-
Cellular signals converge at the NOX2-SHP-2 axis to induce reductive carboxylation in cancer cells. Cell Chem Biol. 2022 07 21; 29(7):1200-1208.e6.
-
Fibroblast pyruvate carboxylase is required for collagen production in the tumour microenvironment. Nat Metab. 2021 11; 3(11):1484-1499.
-
Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival. Blood Cancer Discov. 2022 01; 3(1):50-65.
-
Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease. Front Immunol. 2021; 12:757836.